Strategy developed to improve delivery of medicines to the brain.
New research offers a possible strategy for treating central nervous system diseases, such as brain and spinal cord injury, brain cancer, epilepsy, and neurological complications of HIV. The experimental treatment method allows small therapeutic agents to safely cross the blood-brain barrier in laboratory rats by turning off P-glycoprotein, one of the main gatekeepers preventing medicinal drugs from reaching their intended targets in the brain.
To read the full text of this article, click here: http://www.nih.gov/news/health/sep2012/niehs-07.htm
|Printer friendly Cite/link Email Feedback|
|Publication:||National Institutes of Health: News and Events|
|Article Type:||Brief article|
|Date:||Sep 7, 2012|
|Previous Article:||TCGA discovers potential therapeutic targets for lung squamous cell carcinoma.|
|Next Article:||NIBIB and HHMI announce graduate biomedical training awards.|